March 1, 2022
The Ministry of Health, Labor and Welfare (MHLW) on February 28 started distributing Pfizer’s oral COVID-19 treatment Paxlovid (nirmatrelvir/ritonavir) to medical institutions across Japan, but on the condition that the drug will be dispensed in-house. Since Paxlovid is contraindicated with...read more